Phospho-TH (S62) Antibody

What is Phospho-TH (S62) Antibody and what does it detect?

Phospho-TH (S62) Antibody is a phosphorylation state-specific antibody that recognizes tyrosine hydroxylase (TH) only when phosphorylated at the Serine-62 residue. TH is the rate-limiting enzyme in dopamine biosynthesis, and its activity is regulated through phosphorylation at multiple serine residues, including Ser-62 . The antibody is typically generated using synthetic phosphopeptides derived from human TH protein sequences surrounding the Ser-62 phosphorylation site . This high specificity enables researchers to study the phosphorylation status of TH at this particular residue independently of other phosphorylation events.

How does Phospho-TH (S62) Antibody differ from other TH phospho-antibodies?

Phospho-TH (S62) Antibody specifically recognizes TH phosphorylated at Serine-62, distinguishing it from antibodies targeting other phosphorylation sites such as Ser-40 . While Ser-40 phosphorylation is well-established for regulating DA synthesis and responsive to stimuli that alter dopaminergic neural activity , Ser-62 phosphorylation represents a different regulatory mechanism. Each phosphorylation site-specific antibody enables researchers to investigate distinct aspects of TH regulation. For example, phosphorylation at Ser-40 is known to be particularly important for relief of inhibitory dopamine binding to TH and increasing TH activity , whereas the specific role of Ser-62 phosphorylation may involve different regulatory pathways or responses to different stimuli.

What are the typical applications for Phospho-TH (S62) Antibody?

The Phospho-TH (S62) Antibody is validated for several experimental applications:

• Western Blotting: Recommended dilution ratios range from 1:500 to 1:2000

• Immunohistochemistry: Recommended dilution ratios range from 1:100 to 1:300

• ELISA: Recommended dilution ratio of 1:5000

The antibody has demonstrated effective detection of endogenous levels of TH protein phosphorylated at S62 in human and other mammalian models, with confirmed reactivity in human, mouse, rat, and monkey samples . The phosphorylated TH protein typically appears at approximately 60 kDa on Western blots .

What are the optimal sample preparation methods for Phospho-TH (S62) Antibody detection?

For optimal detection of phosphorylated TH at Ser-62, samples should be preserved with phosphatase inhibitors immediately after collection to prevent dephosphorylation. Cell and tissue lysates should be prepared in buffer containing phosphatase inhibitors such as sodium fluoride, sodium orthovanadate, and phosphatase inhibitor cocktails. For Western blotting, samples should be denatured at 95°C for 5 minutes in SDS sample buffer prior to gel loading .

For immunohistochemistry, tissue fixation with 4% paraformaldehyde is recommended, though phospho-epitopes can be sensitive to fixation conditions. Some researchers use a combination of paraformaldehyde and glutaraldehyde to better preserve phosphorylation status. Following fixation, antigen retrieval methods may be necessary, but must be optimized to avoid dephosphorylation.

For experiments involving dopaminergic pathways, it's important to note that dopamine synthesis manipulation can affect TH phosphorylation states. For instance, administering a decarboxylase inhibitor like NSD-1015 (100 mg/kg, i.p.) allows for DOPA accumulation measurement as an indicator of TH activity .

How can researchers validate the specificity of Phospho-TH (S62) Antibody?

To validate antibody specificity, researchers should implement several controls:

• Phosphatase treatment: Treating one sample with lambda phosphatase before immunoblotting should eliminate the signal if the antibody is truly phospho-specific.

• Competing peptide assay: Pre-incubating the antibody with the phosphopeptide immunogen should block specific binding.

• Positive and negative controls: Using samples known to contain phosphorylated TH (such as brain tissue stimulated with agents known to induce TH phosphorylation) versus samples where phosphorylation is minimized.

• Cross-reactivity testing: Comparing reactivity with non-phosphorylated TH protein to confirm specificity for the phosphorylated form.

• Knockout/knockdown validation: Using TH knockout tissues or knockdown cells to confirm signal specificity.

The manufacturer data indicates the antibody was validated using 293 cells, showing specific detection of phosphorylated TH at Ser-62 without cross-reactivity to non-phosphorylated TH or other phosphorylation sites .

What factors can affect Phospho-TH (S62) detection in experimental samples?

Several factors can impact the detection of phosphorylated TH at Ser-62:

• Rapid dephosphorylation: Phosphorylation is dynamic and can be rapidly lost due to endogenous phosphatases. Immediate sample processing with phosphatase inhibitors is crucial.

• Stimulus conditions: The phosphorylation state of TH changes in response to various stimuli. For example, studies with phospho-TH(Ser40) have shown that treatments affecting dopaminergic neuron firing (like d-amphetamine) can alter phosphorylation levels .

• Tissue-specific variations: Phosphorylation levels may differ between brain regions. Studies have shown different phosphorylation patterns in structures like the ventral tegmental area (VTA), substantia nigra (SN), caudate putamen (CPu) and nucleus accumbens (NAc) .

• Physiological state: Conditions such as food restriction (FR) have been shown to affect TH protein levels and phosphorylation status .

• Cross-reactivity: While manufacturer data indicates high specificity, antibodies may occasionally cross-react with similar phospho-epitopes in other proteins.

How can Phospho-TH (S62) Antibody be used to study dopaminergic pathways in neurological disorders?

Phospho-TH (S62) Antibody offers valuable insights into dopaminergic dysfunction in neurological disorders:

• Parkinson's Disease: Researchers can examine changes in TH phosphorylation patterns at Ser-62 in animal models of Parkinson's disease or postmortem human brain tissue to understand how this specific phosphorylation site may be dysregulated in the disease process.

• Drug addiction: Studies investigating how drugs of abuse affect dopamine synthesis can utilize this antibody to examine if substances like amphetamines alter TH phosphorylation at Ser-62. Previous research has shown that d-amphetamine administration (0.5 and 5.0 mg/kg, i.p.) selectively decreased phospho-Ser(40)-TH in nucleus accumbens of food-restricted rats , and similar approaches could be applied to study Ser-62 phosphorylation.

• Comparative phosphorylation analysis: Researchers can compare phosphorylation at Ser-62 versus other sites like Ser-40 to develop a comprehensive understanding of TH regulation in different pathological states. This is particularly important since different phosphorylation sites may respond differently to the same stimulus.

• Therapeutic development: By understanding the specific signaling pathways regulating TH phosphorylation at Ser-62, researchers may identify novel therapeutic targets for disorders involving dopamine dysregulation.

• Biomarker development: Changes in TH phosphorylation patterns could potentially serve as biomarkers for disease progression or treatment response in dopamine-related disorders.

How does phosphorylation at Ser-62 relate to other TH phosphorylation sites in regulating enzyme activity?

TH is regulated by multiple phosphorylation sites, with Ser-62 representing one component of this complex regulatory system:

• Hierarchical phosphorylation: While Ser-40 phosphorylation directly increases TH activity by relieving dopamine-mediated feedback inhibition , Ser-62 phosphorylation may work in concert with other sites in a hierarchical manner.

• Kinase specificity: Different kinases target specific phosphorylation sites on TH. Research suggests that while Ser-40 is phosphorylated by PKA, Ser-62 may be targeted by different kinases, potentially including MAP kinases, creating independent regulatory pathways.

• Temporal dynamics: Different phosphorylation sites may have distinct temporal patterns of activation and inactivation in response to stimuli. Researchers can use the Phospho-TH (S62) Antibody alongside antibodies for other phosphorylation sites to examine these temporal relationships.

• Functional consequences: Ser-40 phosphorylation is known to increase the Vmax of TH and decrease the Km for the pteridine cofactor , but the specific enzymatic consequences of Ser-62 phosphorylation require further investigation using this antibody.

• Integration with other posttranslational modifications: TH activity is also regulated by other modifications beyond phosphorylation, and Ser-62 phosphorylation may interact with these mechanisms.

What experimental designs can resolve contradictory data in TH phosphorylation studies?

Researchers frequently encounter contradictory data when studying TH phosphorylation. The following experimental approaches can help resolve these contradictions:

• Combined in vivo and in vitro approaches: Studies have shown that in vivo DOPA accumulation measurements may yield different results than expected based on TH protein levels or phosphorylation state . Using multiple approaches provides a more complete picture.

• Temporal resolution studies: Capturing phosphorylation dynamics across multiple time points may resolve apparent contradictions resulting from different sampling times.

• Regional specificity analysis: TH regulation differs between brain regions. For example, one study found different phospho-TH responses to d-amphetamine in NAc compared to other regions . Detailed regional analysis using the Phospho-TH (S62) Antibody for immunohistochemistry can identify region-specific regulatory mechanisms.

• Consideration of cofactor availability: TH activity depends not only on phosphorylation but also on cofactor availability. Decreased DOPA synthesis despite increased TH protein levels may reflect "inhibitory effect of increased DA binding to TH protein or decreased concentrations of cofactor tetrahydrobiopterin" .

• Multi-site phosphorylation analysis: Simultaneous examination of multiple phosphorylation sites using different phospho-specific antibodies can reveal interactions between sites that explain seemingly contradictory results.

How can researchers overcome weak or non-specific signals when using Phospho-TH (S62) Antibody?

When encountering signal issues with Phospho-TH (S62) Antibody, researchers can implement these strategies:

• Optimize antibody concentration: Adjust the dilution ratios within the recommended ranges (1:500-1:2000 for WB, 1:100-1:300 for IHC) to find optimal conditions for your specific samples.

• Enhance phosphatase inhibition: Use fresh, robust phosphatase inhibitor cocktails during sample preparation, and maintain cold temperatures throughout processing to preserve phosphorylation status.

• Modify blocking conditions: Test different blocking solutions (BSA vs. milk) and durations to minimize background while preserving specific signal. Note that milk contains phosphatases and should be avoided when detecting phosphoproteins.

• Signal enhancement systems: Consider using amplification systems like biotin-streptavidin or tyramide signal amplification for detecting low-abundance phosphorylated proteins.

• Sample enrichment: For low-abundance samples, consider phosphoprotein enrichment using techniques like metal oxide affinity chromatography (MOAC) or immunoprecipitation prior to analysis.

• Optimize antigen retrieval: For IHC applications, systematically test different antigen retrieval methods (heat-induced vs. enzymatic) to maximize epitope accessibility while preserving phosphorylation.

What strategies can improve quantification of TH phosphorylation levels in complex tissue samples?

Accurate quantification of phosphorylated TH in complex samples requires careful methodology:

• Normalization approaches: Always normalize phospho-TH signals to total TH protein levels to account for variations in total TH expression. This requires parallel detection with both phospho-specific and total TH antibodies.

• Internal loading controls: Include consistent loading controls like GAPDH or β-actin alongside phospho-specific detection.

• Standard curve generation: For absolute quantification, create standard curves using recombinant phosphorylated TH protein at known concentrations.

• Multiple detection methods: Validate Western blot findings with complementary techniques like ELISA or phospho-flow cytometry when possible.

• Consider regional heterogeneity: Brain tissue contains varying proportions of dopaminergic neurons. Cell sorting or laser capture microdissection can isolate specific cell populations before analysis.

• Phosphorylation stoichiometry: To determine the proportion of TH molecules phosphorylated at Ser-62, researchers can employ techniques like Phos-tag gels that separate phosphorylated from non-phosphorylated proteins.

How can Phospho-TH (S62) Antibody be integrated with advanced imaging techniques?

Integration of Phospho-TH (S62) Antibody with cutting-edge imaging approaches enables spatial and temporal insights into TH regulation:

• Super-resolution microscopy: Techniques like STED or STORM combined with Phospho-TH (S62) Antibody immunofluorescence can reveal subcellular localization patterns of phosphorylated TH at nanoscale resolution.

• Multiplexed imaging: Simultaneous detection of multiple TH phosphorylation sites using different fluorophores can map the spatiotemporal relationships between phosphorylation events.

• Live cell imaging: While challenging with phospho-specific antibodies, phospho-mimetic sensors combined with conventional antibody validation could enable real-time monitoring of TH phosphorylation dynamics.

• Tissue clearing techniques: Methods like CLARITY or iDISCO can be combined with Phospho-TH (S62) Antibody to visualize TH phosphorylation networks throughout intact brain circuits.

• Correlative light and electron microscopy (CLEM): This approach can connect phospho-TH detection with ultrastructural features, revealing how phosphorylation states relate to synaptic architecture.

What are the emerging applications of Phospho-TH (S62) Antibody in understanding synaptic plasticity?

Recent research suggests important connections between TH phosphorylation and synaptic function:

• Activity-dependent phosphorylation: Examining how neuronal activity patterns regulate TH phosphorylation at Ser-62 may reveal mechanisms linking dopamine synthesis to synaptic activity.

• Integration with other phosphorylated synaptic proteins: Co-detection of phosphorylated TH with phosphorylated synaptic proteins like Synapsin (which is phosphorylated at Ser-9 ) can reveal coordinated regulation of presynaptic function.

• Plasticity mechanisms: Investigating how learning paradigms affect TH phosphorylation patterns may uncover mechanisms connecting dopamine synthesis regulation to memory formation.

• Circuit-specific regulation: Combining circuit tracing methods with phospho-TH detection can reveal how specific neural pathways modulate dopamine synthesis through differential phosphorylation.

• Cross-talk with other neurotransmitter systems: Research into how glutamatergic or GABAergic signaling affects TH phosphorylation may reveal mechanisms of neurotransmitter system interaction important for synaptic plasticity.

How does TH phosphorylation at Ser-62 compare across different model systems and human samples?

Understanding species and model differences in TH phosphorylation is critical for translational research:

What novel experimental paradigms can reveal the functional significance of TH phosphorylation at Ser-62?

To determine the specific roles of Ser-62 phosphorylation in TH function:

• Site-directed mutagenesis: Creating phosphomimetic (S62D/E) and phosphodeficient (S62A) TH mutants for expression in cell models or in vivo can directly test the functional consequences of Ser-62 phosphorylation.

• Kinase and phosphatase manipulation: Identifying and selectively inhibiting the kinases and phosphatases that regulate Ser-62 phosphorylation can reveal the upstream regulatory pathways.

• Phosphorylation-dependent protein interactions: Proteomic approaches using phosphorylated versus non-phosphorylated TH peptides as bait can identify proteins that specifically interact with TH when phosphorylated at Ser-62.

• High-throughput screening: Developing cell-based assays to measure Ser-62 phosphorylation enables screening of compound libraries to identify modulators of this specific phosphorylation event.

• In vivo optogenetic or chemogenetic approaches: Combining selective activation of neural circuits with phospho-TH analysis can identify pathways that regulate TH through Ser-62 phosphorylation.